why choose us

First received: February 20, 2023

Clinical Trial: Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Plasmodium Falciparum Infection

Study Type: INTERVENTIONAL


Official Title: Exposure-Response Evaluation of IV Artesunate in Children With Severe Malaria

Brief Summary: This clinical study is a phase 4, single-site, open-label pharmacokinetic (PK) study of IV artesunate in up to 100 Ugandan children 6 months-14 years of age who are diagnosed with severe malaria according to standardized World Health Organization (WHO) criteria (any P. falciparum parasitemia and the presence of danger signs).Participants will receive the standard of care IV artesunate for initial treatment of severe malaria per WHO guidelines: children weighing <20 kg should receive 3.0 mg/kg/dose…

Read more